ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

Sausville to lead clinical research at Maryland.

December 5, 2003

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

DRCA Board Okays Concepts For Five Contract Projects

June 25, 1981

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

December 12, 1980